AVO announces £110m prospective recapitalisation plan

Advanced Oncotherapy (AVO) today announced a prospective recapitalisation and funding plan to raise up to £110m. Earlier this month, the company’s shares were suspended from trading…

You must be a HM Subscriber to view this content.

Subscribe Now »